Sermion



Indications and Reactions:

Role Indications Reactions
Secondary
Cerebral Infarction 10.9%
Drug Use For Unknown Indication 10.9%
Gastritis 10.3%
Cardiac Failure Chronic 7.7%
Lumbar Spinal Stenosis 7.7%
Product Used For Unknown Indication 7.7%
Cardiac Failure 5.1%
Glaucoma 5.1%
Prophylaxis 5.1%
Dementia Alzheimer's Type 3.8%
Insomnia 3.2%
Diarrhoea 2.6%
Dry Eye 2.6%
Enterocolitis 2.6%
Hepatic Function Abnormal 2.6%
Hypertension 2.6%
Hyperuricaemia 2.6%
Lacunar Infarction 2.6%
Neuropathy Peripheral 2.6%
Depression 1.9%
Fall 12.5%
Sudden Cardiac Death 12.5%
Pulmonary Fibrosis 9.4%
Death 6.3%
Hallucination, Visual 6.3%
Pancytopenia 6.3%
Sudden Death 6.3%
Blood Creatine Phosphokinase Increased 3.1%
Duodenal Ulcer Haemorrhage 3.1%
General Physical Health Deterioration 3.1%
Hypercalcaemia 3.1%
Hypertension 3.1%
Hypotension 3.1%
Inflammatory Carcinoma Of The Breast 3.1%
Orthostatic Hypotension 3.1%
Rales 3.1%
Retroperitoneal Fibrosis 3.1%
Surgery 3.1%
Toxic Skin Eruption 3.1%
Vomiting 3.1%
Concomitant
Hypertension 18.8%
Drug Use For Unknown Indication 14.4%
Product Used For Unknown Indication 11.1%
Cerebral Infarction 10.1%
Constipation 5.4%
Rheumatoid Arthritis 5.1%
Insomnia 4.4%
Osteoporosis 3.9%
Gastritis 3.7%
Dementia Alzheimer's Type 3.4%
Herpes Zoster 3.1%
Parkinson's Disease 2.4%
Prophylaxis 2.4%
Depression 2.3%
Diabetes Mellitus 1.9%
Gastric Ulcer 1.9%
Angina Pectoris 1.6%
Non-small Cell Lung Cancer 1.5%
Cardiac Failure 1.4%
Chest Pain 1.4%
Pneumonia Aspiration 9.2%
Hepatic Function Abnormal 7.7%
Osteitis 6.3%
Renal Impairment 6.3%
Thrombocytopenia 6.3%
Pyrexia 5.6%
Vomiting 5.6%
Transient Ischaemic Attack 4.9%
Urinary Retention 4.9%
Cerebral Infarction 4.2%
Renal Failure Chronic 4.2%
Rhabdomyolysis 4.2%
Somnolence 4.2%
Upper Gastrointestinal Haemorrhage 4.2%
White Blood Cell Count Decreased 4.2%
Hypersomnia 3.5%
International Normalised Ratio Increased 3.5%
Malaise 3.5%
Oedema Peripheral 3.5%
Tremor 3.5%